Stock & Company Details
Heron Therapeutics Inc $HRTX
Price:
N/A
N/A
190M
$68M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.03
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
HRTX technical indicators
Latest Heron Therapeutics Inc (HRTX) indicator readings as of 2026-10-09.
HRTX's 14-day RSI is 63.3, in neutral territory. At $0.41 it is trading 47.6% below its 200-day moving average of $0.78, and above its 50-day average of $0.35. Price sits above the upper Bollinger Band ($0.25 to $0.40). ADX reads 27.4, indicating a trending market.
Overview
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.
Finance Bot
Ask your questions
Start by typing a question below.
